Evoq Technologies Email Formats

About Evoq Technologies

Reshaping Retinal Diagnostics Evoq Technologies is transforming vision care with wearable, accessible diagnostics that detect retinal and neurological diseases earlier than ever—before vision is lost. Our Mission: To make early detection scalable and functional. We deliver mobile, cloud-connected devices that outperform imaging by testing function at the earliest stage of disease—empowering care in clinics or at home. Breakthrough Product Line 🔹 Twilight™ – Class I wearable for self-administered dark adaptation testing to detect nyctalopia, a key early sign of AMD. 🔹 SmartERG® – Smartphone-based full-field ERG/VEP for inherited retinal diseases, DR, and veterinary use. 🔹 Gleam™ – Full-field threshold test in development for late-stage inherited retinal disease. 🔹 DAP – A 5x5 ft. dark enclosure for standardized clinic and research testing. 🔹 SightGard™ – A HIPAA-compliant, AI-ready cloud for longitudinal retinal data. Why We're Different Function over form – Detects dysfunction before structural changes appear. Wearable & smart – Portable, easy-to-use tools that fit standard workflows. Diagnostics-as-a-Service – Subscription-based model breaks cost barriers. Data-driven – Over 50,000 scans expected by 2026, fueling AI and clinical research. The Need • 50%+ of early retinal diseases missed by imaging • 19M+ Americans with AMD; doubling by 2050 • 1 in 8 seniors experiences night vision loss • Early detection lowers costs & improves outcomes 🤝 Join us—researchers, clinicians, and investors—as we shape the future of diagnostics. #RetinalHealth #earlydetection

View contact profiles from Evoq Technologies